Compared with the patients in the EOT2D-uncombined NAFLD group, the EOT2D-combined NAFLD group had significantly higher levels of BMI, FINS, FCP, FBG, HbA1c, ALT, AST, ALB, GGT, UA, TG, TC, NHHR, WBC, N, L, M, and PLT (P < 0.05) (see Table 3). Here, ALB is linked to metabolic dysfunction-associated steatotic liver disease.